Alcoholic Hepatitis Treatment Market is projected to reach US$ 5.3 Billion by end of 2033, with growth rate of 6.5% CAGR through 2033

A Significant Unmet Medical Need for Effective Treatments for Alcoholic Hepatitis will drive the Market. North America is leading in the global alcoholic hepatitis treatment market with a 39.9% market share in 2022 and is expected to continue to do so during the forecasted years due to the increasing prevalence of alcoholic hepatitis.

/EIN News/ — NEWARK, Del, May 15, 2023 (GLOBE NEWSWIRE) — As per Future Market Insights’ latest industry analysis, the valuation for the global alcoholic hepatitis treatment market was around US$ 2.6 Billion in 2022 and is projected to exhibit a CAGR growth of close to 6.5% over the forecast period, with an estimated valuation of US$ 5.3 Billion in 2033.

Alcoholic hepatitis is a serious and potentially life-threatening condition that results from excessive alcohol consumption. It is a type of liver disease that is characterized by inflammation and damage to liver cells. If left untreated, alcoholic hepatitis can lead to liver failure and even death. Due to its severity, patients with alcoholic hepatitis are highly motivated to seek effective treatments that can improve their quality of life and increase their chances of survival.

Unfortunately, there are currently no specific medications that have been approved by regulatory agencies for the treatment of alcoholic hepatitis. This lack of effective treatments has created a significant unmet need in the market, driving demand for new and innovative therapies.

As a result, there is intense research and development activity in the alcoholic hepatitis treatment market aimed at developing new drugs, medical devices, and minimally invasive procedures that can effectively treat the disease. Many pharmaceutical and biotechnology companies are investing heavily in the development of novel therapies for alcoholic hepatitis, which is expected to drive the growth of the market in the coming years.

Drivers and Challenges have an Impact on Market Dynamics, which can Impact your Business. Find more details in our Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-17191

Also, governments are implementing policies aimed at improving access to healthcare, particularly for underserved and vulnerable populations. This is driving demand for alcoholic hepatitis treatment and making it more accessible to patients.

Overall, these factors are contributing to the growth of the alcoholic hepatitis treatment market, and are expected to continue to drive demand for effective and innovative treatment options in the coming years.

Key Takeaways:

• Drug treatment is the leading segment as treatment among patients and professionals, and held about 88.3% market share in 2022, due to its non-invasive nature and high efficacy in patients.
• By route of administration, the oral segment is leading with a 78.2% market share in 2022 as oral medications are often the first-line treatment for alcoholic hepatitis because they are effective and relatively easy to administer.
• By distribution channel, institutional sales dominated the global alcoholic hepatitis treatment market withholding the total market share of about 55.9% by the end of 2022 as healthcare institutions such as hospitals, clinics, and long-term care facilities provide a wide range of services and treatments for patients with alcoholic hepatitis.
• By region, North America is leading in the global alcoholic hepatitis treatment market with a 39.9% market share in 2022 and is expected to continue to do so during the forecasted years due to the increasing prevalence of alcoholic hepatitis.

“Increasing adoption of stem cell therapies and growing awareness and diagnosis of alcoholic hepatitis to create the lucrative potential for the market in near future,” says an analyst at Future Market Insights (FMI).

Are you looking for more details about latest trends, drivers, and challenges? Speak to Our Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-17191

Market Competition:

Manufacturers are focusing on collaboration with academic institutions, research organizations, and other pharmaceutical companies to advance research and development initiatives. Manufacturers engage in aggressive marketing and promotion strategies to increase the visibility and awareness of their products among healthcare providers. Pharmaceutical companies invest heavily in research and development to develop new and innovative drugs for the treatment of alcoholic hepatitis.

• In March 2021, Mallinckrodt plc won the Manufacturing Leadership Award for outstanding achievement in two categories – Collaborative Innovation Leadership and Operational Excellence Leadership – from the National Association of Manufacturers (NAM).

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the alcoholic hepatitis treatment market in its latest study, presenting a historical demand assessment of 2012 – 2022 and projections for 2023 – 2033. The global alcoholic hepatitis treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on treatment– alcoholic hepatitis treatment market by treatment – [drug treatment (acamprosate, naltrexone, pentoxifylline, infliximab, corticosteroids, benzodiazepines, nutritional supplements, others), stem cell therapy], route of administration (oral, injectable), distribution channel – [institutional sales (hospitals, stem cell centers, stem cell centers, cancer research institutes), retail sales (retail pharmacies, e-commerce/mail order pharmacies)], across seven regions of the world.

Key Players:

• F. Hoffmann-La Roche Ltd (Genentech, Inc)
• Teva Pharmaceuticals
• Pfizer
• Alkermes, Inc
• Viatris Inc
• Merck KGaA
• Sun Pharmaceutical Industries Ltd
• Hikma Pharmaceuticals PLC
• H. Lundbeck A/S
• Mallinckrodt
• Glenmark Pharmaceuticals U.S. Inc
• Torrent Pharmaceuticals Ltd
• Wellona Pharma

Buy Now and Gain Access to Identify Key Trends, Drivers, and Challenges in the Market @ https://www.futuremarketinsights.com/checkout/17191

Key Segments Covered

By Treatment:

• Drug Treatment
  • Acamprosate
  • Naltrexone
  • Pentoxifylline
  • Infliximab
  • Corticosteroids
  • Benzodiazepines
  • Nutritional Supplements
  • Others
• Stem Cell Therapy

By Route of Administration:

By Distribution Channel:

Stem Cell Centers

• Specialized Clinics
• Cancer Research Institutes

• Retail Sales
  • Retail Pharmacies
  • E- Commerce/Mail Order Pharmacies

Table of Content (ToC):

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

4. Value-Added Insights

    4.1. Product Adoption / Usage Analysis

    4.2. Disease spectrum

    4.3. Algorithm For The Evaluation And Management of Patients with Alcoholic Liver Disease

    4.4. Therapeutic Algorithm Of Alcoholic Liver Disease

    4.5. Regulatory Scenario

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

Have a Look at Related Research Reports in the Healthcare Domain:

USA Animal Model Market Size: The USA animal model market valuation reached around US$ 947.3 Million back in 2022. The demand in the USA animal model is set to increase at a 4.3% CAGR from 2023 to 2033.

Dental Sealants Market Share: The dental sealants market is estimated to secure a valuation of US$ 1 Billion in 2023 and is predicted to reach US$ 1.6 Billion by 2033. The market is capturing a CAGR of 4.5% during the forecast period.

Single-use Gastroscopes Market Growth: According to Future Market Insights (FMI) analysis in a recent market survey, the global single-use gastroscopes market was valued at US$ 167.2 Million in 2022 and is expected to reach US$ 807.8 Million by 2033.

Celiac Disease Diagnostics Market Forecast: According to Future Market Insights (FMI) analysis in a recent market survey, the global celiac disease diagnostics market was valued at US$ 271.3 Million in 2022 and is expected to reach US$ 647.3 Million by 2033.

Extraction Kits Market Application: The global demand for extraction kits is expected to increase at 7.1% CAGR over the forecast period. The extraction kits market size is estimated to reach a valuation of US$ 1,293.4 Million by 2023.

Over-The-Counter (OTC) Veterinary Drugs Market Analysis: The over-the-counter (OTC) veterinary drugs market is expected to expand its roots at a steady CAGR of 7.9% during the forecast period. The market is likely to hold a revenue of US$ 8.8 Billion in 2023 while it is anticipated to cross a value of US$ 19.01 Billion by 2033.

Anti-Osteoporosis Therapy and Fracture Healing Market Outlook: The global anti-osteoporosis therapy and fracture healing market is expected to attain a valuation of US$ 14,051.6 Million in 2023. The market is projected to reach US$ 22,427.6 Million by 2033, anticipated to expand at a CAGR of 4.8% during the forecast period.

Hyaluronic Acid Products Market Sales: The global hyaluronic acid products market is expected to attain a valuation of US$ 3,343.5 Million in 2023 and is projected to reach US$ 6,838.2 Million by 2033, rising at a CAGR of 7.4% during the forecast period.

Protein Diagnostics Market Volume: According to Future Market Insights (FMI) analysis in a recent market survey, the global protein diagnostics market was valued at US$ 4.7 Billion in 2022 and is expected to reach US$ 8.3 Billion by 2033.

Prurigo Nodularis Treatment Market Demand: The global prurigo nodularis treatment market is expected to attain a valuation of US$ 693.3 Million in 2023 and is projected to reach US$ 930.9 Million by 2033. The market is expected to rise at a CAGR of 3% from 2023 to 2033.

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.

Contact Us:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: [email protected]